{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:46:40Z","timestamp":1791406000274,"version":"4.3.3"},"reference-count":49,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T00:00:00Z","timestamp":1369180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Coronaviruses infect a variety of mammalian and avian species and cause serious diseases in humans, cats, mice, and birds in the form of severe acute respiratory syndrome (SARS), feline infectious peritonitis (FIP), mouse hepatitis, and avian infectious bronchitis, respectively. No effective vaccine or treatment has been developed for SARS-coronavirus or FIP virus, both of which cause lethal diseases. It has been reported that a cyclophilin inhibitor, cyclosporin A (CsA), could inhibit the replication of coronaviruses. CsA is a well-known immunosuppressive drug that binds to cellular cyclophilins to inhibit calcineurin, a calcium-calmodulin-activated serine\/threonine-specific phosphatase. The inhibition of calcineurin blocks the translocation of nuclear factor of activated T cells from the cytosol into the nucleus, thus preventing the transcription of genes encoding cytokines such as interleukin-2. Cyclophilins are peptidyl-prolyl isomerases with physiological functions that have been described for many years to include chaperone and foldase activities. Also, many viruses require cyclophilins for replication; these include human immunodeficiency virus, vesicular stomatitis virus, and hepatitis C virus. However, the molecular mechanisms leading to the suppression of viral replication differ for different viruses. This review describes the suppressive effects of CsA on coronavirus replication.<\/jats:p>","DOI":"10.3390\/v5051250","type":"journal-article","created":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T12:45:12Z","timestamp":1369226712000},"page":"1250-1260","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":141,"title":["Suppression of Coronavirus Replication by Cyclophilin Inhibitors"],"prefix":"10.3390","volume":"5","author":[{"given":"Yoshikazu","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Veterinary Hygiene, Veterinary School, Nippon Veterinary & Life Science University, Tokyo 180-8602, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Division of Molecular Virology, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Laboratory of Bacterial Genomics, Pathogen Genomics Center, National Institute of Infectious Diseases, Tokyo 162-8640, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2013,5,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-sars: Update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature04735","article-title":"A mechanical explanation of RNA pseudoknot function in programmed ribosomal frameshifting","volume":"441","author":"Namy","year":"2006","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/JVI.01358-06","article-title":"A contemporary view of coronavirus transcription","volume":"81","author":"Sawicki","year":"2007","journal-title":"J. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/eji.1830170921","article-title":"Cyclophilin binds to the region of cyclosporine involved in its immunosuppressive activity","volume":"17","author":"Quesniaux","year":"1987","journal-title":"Eur. J. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1186\/gb-2005-6-7-226","article-title":"The cyclophilins","volume":"6","author":"Wang","year":"2005","journal-title":"Genome Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/355033a0","article-title":"Protein folding in the cell","volume":"355","author":"Gething","year":"1992","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.bbabio.2008.03.009","article-title":"Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore","volume":"1777","author":"Leung","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"26312","DOI":"10.1074\/jbc.M805235200","article-title":"The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition","volume":"283","author":"Leung","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"22322","DOI":"10.1074\/jbc.M400736200","article-title":"The human nuclear srcyp is a cell cycle-regulated cyclophilin","volume":"279","author":"Dubourg","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_10","first-page":"127","article-title":"The 20kD protein of human [U4\/U6.U5] tri-snRNPs is a novel cyclophilin that forms a complex with the U4\/U6-specific 60kD and 90kD proteins","volume":"4","author":"Teigelkamp","year":"1998","journal-title":"RNA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1073\/pnas.90.2.542","article-title":"A cyclophilin-related protein involved in the function of natural killer cells","volume":"90","author":"Anderson","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbrc.2012.07.024","article-title":"Cyclophilin A and viral infections","volume":"424","author":"Zhou","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1253\/circj.CJ-10-0904","article-title":"Cyclophilin A: Promising new target in cardiovascular therapy","volume":"74","author":"Satoh","year":"2010","journal-title":"Circ. J."},{"key":"ref_14","first-page":"RA221","article-title":"Cyclophilin A: Potential functions and therapeutic target for human cancer","volume":"15","author":"Obchoei","year":"2009","journal-title":"Med. Sci. Monit."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0092-8674(93)90637-6","article-title":"Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B","volume":"73","author":"Luban","year":"1993","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molcel.2005.05.014","article-title":"Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase","volume":"19","author":"Watashi","year":"2005","journal-title":"Mol. Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1099\/vir.0.19074-0","article-title":"Requirement for cyclophilin a for the replication of vesicular stomatitis virus new jersey serotype","volume":"84","author":"Bose","year":"2003","journal-title":"J. Gen. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e1000524","DOI":"10.1371\/journal.ppat.1000524","article-title":"Target cell cyclophilins facilitate human papillomavirus type 16 infection","volume":"5","author":"Patel","year":"2009","journal-title":"PLoS Pathog."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9052","DOI":"10.1128\/JVI.77.16.9052-9068.2003","article-title":"Redistribution of cyclophilin a to viral factories during vaccinia virus infection and its incorporation into mature particles","volume":"77","author":"Castro","year":"2003","journal-title":"J. Virol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1128\/jvi.69.4.2451-2461.1995","article-title":"Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: Interference with hiv protein-cyclophilin a interactions","volume":"69","author":"Billich","year":"1995","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1128\/AAC.01324-07","article-title":"Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent","volume":"52","author":"Ptak","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.bbrc.2006.03.059","article-title":"Evaluation of the anti-hepatitis C virus effects of cyclophilin inhibitors, cyclosporin A, and NIM811","volume":"343","author":"Goto","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/AAC.00660-09","article-title":"Scy-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of hepatitis C virus RNA replication in vitro","volume":"54","author":"Hopkins","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/hep.21102","article-title":"The non-immunosuppressive cyclosporin Debio-025 is a potent inhibitor of hepatitis C virus replication in vitro","volume":"43","author":"Paeshuyse","year":"2006","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1099\/vir.0.034983-0","article-title":"Cyclosporin a inhibits the replication of diverse coronaviruses","volume":"92","author":"Thiel","year":"2011","journal-title":"J. Gen. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e1002331","DOI":"10.1371\/journal.ppat.1002331","article-title":"The SARS-coronavirus-host interactome: Identification of cyclophilins as target for pan-coronavirus inhibitors","volume":"7","author":"Pfefferle","year":"2011","journal-title":"PLoS Pathog."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1186\/1297-9716-43-41","article-title":"Suppression of feline coronavirus replication in vitro by cyclosporin A","volume":"43","author":"Tanaka","year":"2012","journal-title":"Vet. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jfms.2008.09.008","article-title":"A review of feline infectious peritonitis virus infection: 1963\u20132008","volume":"11","author":"Pedersen","year":"2009","journal-title":"J. Feline Med. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2460\/ajvr.1981.42.03.368","article-title":"An enteric coronavirus infection of cats and its relationship to feline infectious peritonitis","volume":"42","author":"Pedersen","year":"1981","journal-title":"Am. J. Vet. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"14122","DOI":"10.1128\/JVI.79.22.14122-14130.2005","article-title":"Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein","volume":"79","author":"Rottier","year":"2005","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.vetimm.2008.01.026","article-title":"Treatment of cats with feline infectious peritonitis","volume":"123","author":"Hartmann","year":"2008","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_32","unstructured":"Tanaka, Y., Osawa, S., Inoue, M., Tanaka, S., and Sato, Y. (2010, January 17\u201321). Inhibition of Feline Infectious Peritonitis Viral Replication by Cyclosporine. Proceedings of the 29th Annual Meeting of the American Society for Virology, Bozeman, MN, USA. Abstract 55."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1128\/JVI.02078-12","article-title":"Cyclophilin inhibitors block arterivirus replication by interfering with viral RNA synthesis","volume":"87","author":"Li","year":"2013","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.virol.2011.01.011","article-title":"Involvement of cyclophilin B in the replication of Japanese encephalitis virus","volume":"412","author":"Kambara","year":"2011","journal-title":"Virology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1128\/AAC.00189-09","article-title":"Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein","volume":"53","author":"Qing","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"11620","DOI":"10.1128\/JVI.00702-07","article-title":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: Role of nsp1 and rational design of an attenuated strain","volume":"81","author":"Wathelet","year":"2007","journal-title":"J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1371\/journal.ppat.0030109","article-title":"Coronavirus non-structural protein 1 is a major pathogenicity factor: Implications for the rational design of coronavirus vaccines","volume":"3","author":"Zust","year":"2007","journal-title":"PLoS Pathog."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.virol.2005.06.035","article-title":"Mutagenesis of the murine hepatitis virus nsp1-coding region identifies residues important for protein processing, viral RNA synthesis, and viral replication","volume":"340","author":"Brockway","year":"2005","journal-title":"Virology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.virol.2010.12.061","article-title":"Emerging picture of host chaperone and cyclophilin roles in RNA virus replication","volume":"411","author":"Nagy","year":"2011","journal-title":"Virology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e13687","DOI":"10.1371\/journal.pone.0013687","article-title":"DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin a induced cis-trans isomerisation in domain II of NS5A","volume":"5","author":"Coelmont","year":"2010","journal-title":"PLoS One"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e1000546","DOI":"10.1371\/journal.ppat.1000546","article-title":"Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics","volume":"5","author":"Kaul","year":"2009","journal-title":"PLoS Pathog."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e1001118","DOI":"10.1371\/journal.ppat.1001118","article-title":"A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approach","volume":"6","author":"Yang","year":"2010","journal-title":"PLoS Pathog."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"22959","DOI":"10.1074\/jbc.M201593200","article-title":"Active site residues of cyclophilin A are crucial for its signaling activity via CD147","volume":"277","author":"Yurchenko","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1086\/427811","article-title":"Function of HAb18G\/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus","volume":"191","author":"Chen","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.virol.2009.10.043","article-title":"Multiple cyclophilins involved in different cellular pathways mediate HCV replication","volume":"397","author":"Gaither","year":"2010","journal-title":"Virology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1073\/pnas.111583198","article-title":"CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A","volume":"98","author":"Pushkarsky","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1371\/journal.ppat.0030088","article-title":"Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDS","volume":"3","author":"An","year":"2007","journal-title":"PLoS Pathog."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.10.020","article-title":"Contribution of cyclophilin A to determination of simian immunodeficiency virus tropism: A progress update","volume":"28","author":"Takeuchi","year":"2010","journal-title":"Vaccine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.2174\/1381612043382422","article-title":"Antiviral drugs that target cellular proteins may play major roles in combating hiv resistance","volume":"10","author":"Provencher","year":"2004","journal-title":"Curr. Pharm. Des."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/5\/5\/1250\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:46:54Z","timestamp":1760219214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/5\/5\/1250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,22]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5]]}},"alternative-id":["v5051250"],"URL":"https:\/\/doi.org\/10.3390\/v5051250","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,22]]}}}